Tempus AI SEC Filings

Tempus AI (TEM) Chief Operating Officer reported insider transactions on 11/03/2025. The reporting person’s spouse sold Class A common stock under a Rule 10b5-1 trading plan adopted on March 4, 2025: 500 shares at a weighted average price of $87.24 (range $86.90–$87.80), 2,300 shares at $88.84 (range $88.26–$89.23), and 2,200 shares at $89.64 (range $89.30–$90.28).

Following the reported transactions, beneficial ownership includes 839,180 shares direct; 125,000 shares indirect by spouse; and 131,893 shares indirect by the Ryan Fukushima Irrevocable Family Trust.

Tempus AI (TEM) reported an insider transaction: a director sold 370 shares of Class A common stock on 11/03/2025 at a price of $90 per share. Following the sale, the reporting person beneficially owns 26,671 shares, held directly.

The filing notes the sale was conducted under a Rule 10b5-1 trading plan adopted on August 27, 2024.

Tempus AI (TEM) reported Q3 2025 results marked by rapid growth and continued investment. Total revenue reached $334.2 million, up from $180.9 million a year ago, driven by Genomics $252.9 million and Data and services $81.3 million. Loss from operations was $61.0 million and net loss was $80.0 million, or $0.46 per share.

Balance sheet and cash flows reflected major 2025 actions. Cash and cash equivalents were $655.9 million, with total assets at $2.28 billion. The company issued convertible senior notes, net of discount, of $726.5 million, drew $98.0 million on its revolver, raised $195.5 million via an at‑the‑market equity program, and repaid $276.9 million of long‑term debt. Operating cash outflow was $181.3 million year‑to‑date.

Strategic acquisitions expanded capabilities. Tempus closed the Ambry Genetics acquisition for $375.0 million in cash plus 4,843,136 Class A shares, and acquired Paige.AI for $102.7 million, including 1,272,151 shares and $3.0 million cash, increasing goodwill and intangibles. Remaining performance obligations on limited multi‑year contracts were $360.2 million. As of October 30, 2025, Class A shares outstanding were 172,863,470 and Class B were 5,043,789.

Tempus AI (TEM) furnished an update on Q3 2025. The company issued a press release covering financial results for the quarter ended September 30, 2025, furnished as Exhibit 99.1. It also posted supplemental financial information and a CEO/CFO letter on its investor relations website.

The disclosures under Item 2.02 and Item 7.01 are furnished, not filed, and are not incorporated by reference except as specifically stated.

Tempus AI (TEM) reported insider transactions on Form 4. The reporting person, who is a Director, CEO and Chairman, and 10% owner, executed open‑market sales of Class A Common Stock on 10/28/2025 pursuant to a Rule 10b5‑1 trading plan adopted on March 4, 2025. Tranches were sold at weighted average prices of $87.42, $88.59, $89.50, $90.28, and $91.55, with underlying trade ranges disclosed in the footnotes. Sales were made indirectly through Gray Media, LLC and Blue Media, LLC.

Following the reported transactions, beneficial ownership reported includes: 9,074,532 shares indirectly by Gray Media, LLC and 17,337,470 shares indirectly by Blue Media, LLC. Additional reported holdings include 2,037,500 shares direct, 406 shares indirectly by 346 Long LLC, 10,000,000 shares indirectly by the Lefkofsky Family 2025 GRAT, 206 shares indirectly by Black Media, LLC, and 332,131 shares indirectly by the Lefkofsky Family Foundation.

Tempus AI, Inc. insider filings show that Chief Operating Officer Ryan Fukushima reported multiple dispositions of Class A common stock on 10/06/2025. The sales were executed under a Rule 10b5-1 plan adopted by the reporting person’s spouse on 03/04/2025, and the filing lists stacked disposals reducing several indirect holdings held by spouse, the Ryan Fukushima Irrevocable Family Trust, and directly by Mr. Fukushima. One line reports 839,180 shares sold in aggregate; other reported disposals show weighted-average prices of approximately $90.84, $91.95, and $92.96, with per-trade price ranges disclosed in the footnotes. The form is signed by an attorney-in-fact on 10/08/2025.

Tempus AI insider transactions: Eric P. Lefkofsky, who serves as CEO, Chairman and a >10% owner of Tempus AI (TEM), reported multiple sales of Class A common stock on 09/25/2025 executed under a Rule 10b5-1 trading plan adopted March 4, 2025. The Form 4 lists a series of dispositions in the tens to hundreds of thousands of shares at weighted-average prices ranging from $74.67 to $78.42 per share and a separate disposition of 2,037,500 shares. The filing also shows substantial beneficial holdings held indirectly through entities and trusts, including 10,000,000 shares in the Lefkofsky Family 2025 GRAT and indirect ownership positions exceeding 9 million and 17 million shares by listed vehicles.

Tempus AI, Inc. (TEM) filed a Form 144 notifying a proposed sale of 332,500 Class A common shares through J.P. Morgan Securities LLC with an aggregate market value of $27,973,225, to be sold on 09/25/2025 on Nasdaq. The filing lists the issuer and multiple acquisition lots for the shares, including stock compensation and direct investments dated between 2016 and 2024. The form also discloses several sales by related parties in the prior three months, including individual transactions on 07/28/2025, 08/19/2025, and 08/27/2025. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 procedures if applicable.

Ryan Fukushima, Chief Operating Officer of Tempus AI, Inc. (TEM), reported multiple sales of Class A common stock on September 2, 2025. The Form 4 states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted March 4, 2025. The filing lists a series of dispositions executed at weighted-average prices ranging from about $72.40 to $78.30, with specific weighted-average prices reported for groups of trades (for example, $72.73, $74.00, $74.95, $76.03, $76.77, $78.06). The reported entries show shares sold on that date and indicate indirect beneficial ownership through the reporting person’s spouse and an irrevocable family trust. The Form is signed by an attorney-in-fact on behalf of the reporting person.